Fingerprint
Dive into the research topics of 'Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Tumor response criteria for assessing pazopanib first-line therapy in patients with metastatic renal cell carcinoma (mRCC)
Shiva Gupta, Hyunseon C. Kang, Jia Sun, Marc R. Matrana, Nizar M. Tannir, Haesun Choi
Research output: Contribution to journal › Article › peer-review
1
Scopus
citations